What are the pathophysiology, diagnosis, management, and complications of monoamniotic (monochorionic diamniotic) twins with umbilical cord entanglement and conjoined twins?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Monoamniotic twins and conjoined twins are high-risk pregnancies that require intensive fetal surveillance and management to minimize complications and improve outcomes. The pathophysiology of cord entanglement in monoamniotic twins involves the cords becoming wrapped around each other as the fetuses move, potentially causing compression, reduced blood flow, and fetal demise 1. Diagnosis of monoamniotic twins is made via ultrasound showing a single placenta, no dividing membrane, and same-sex twins, with color Doppler demonstrating cord entanglement. Conjoined twins are diagnosed by ultrasound showing inseparable body parts and lack of membrane between fetuses, with MRI providing additional anatomical detail.

Pathophysiology and Diagnosis

  • Monoamniotic twins develop when a single fertilized egg splits after the formation of the amniotic sac but before the formation of the chorion, resulting in twins sharing one amniotic sac 1.
  • Conjoined twins result from incomplete splitting of the embryonic disc after day 13 post-fertilization, leading to twins who remain physically connected at specific anatomical sites 1.
  • The risk of congenital anomalies seems to be higher for monozygotic twins that separate later, with conjoined twins representing the most extreme example 1.

Management

  • Management of monoamniotic twins typically involves intensive fetal surveillance starting at 24-28 weeks with frequent ultrasounds and non-stress tests, hospitalization from 24-28 weeks until delivery, and planned cesarean delivery at 32-34 weeks after antenatal corticosteroids 1.
  • For conjoined twins, management includes detailed imaging to assess shared organs, multidisciplinary team consultation, and delivery planning via cesarean section, with postnatal surgical separation if feasible based on the extent of organ sharing 1.
  • Fetoscopic laser surgery is recommended as the standard treatment for stage II through stage IV twin-twin transfusion syndrome presenting between 16 and 26 weeks of gestation 1.

Complications

  • Complications of monoamniotic twins include high perinatal mortality (10-20%) primarily from cord entanglement, twin-to-twin transfusion syndrome, and preterm birth 1.
  • Conjoined twins face complications including surgical separation challenges, organ system dysfunction, and psychological impacts, with mortality rates varying from 10-50% depending on the extent and location of connection 1.
  • The risk of adverse outcome, including small for gestational age and sIUGR, lower gestational age at birth, and IUFD, is increased in monochorionic twins with velamentous cord insertion 1.

From the Research

Pathophysiology

  • Monoamniotic twins are at a high risk of perinatal mortality due to unique complications such as cord entanglement and twin-twin transfusion syndrome 2, 3, 4, 5.
  • Cord entanglement is a severe complication in monoamniotic multiple pregnancies, which can lead to intrauterine death of one or both twins 6, 5.
  • The presence of superficial artery-to-artery and vein-to-vein anastomoses and deep arteriovenous shunts in the placenta can also contribute to the pathophysiology of monoamniotic twin pregnancies 6.

Diagnosis

  • Early diagnosis of cord entanglement in monoamniotic twin pregnancies is crucial and can be achieved through ultrasound examination, including color Doppler and pulsed Doppler velocimetry 6.
  • Establishing chorionicity and amniocity in twin pregnancy is an essential part of ultrasound examination to diagnose cord entanglement and predict possible complications 5.
  • Weekly follow-up with special observation of fetal behavior and use of color Doppler velocimetry can help monitor the pregnancy and detect any complications early on 6.

Management

  • Management of monoamniotic twin pregnancies requires a multidisciplinary approach, including generalist obstetrician-gynecologists, maternal-fetal medicine specialists, and nursing staff 3.
  • Hospital admission for fetal monitoring upon discovery of a cord entanglement at a viable gestation is recommended 4.
  • Administration of corticosteroids for fetal lung maturity and timely delivery can improve neonatal outcomes 3.
  • Elective Caesarean section at 32 weeks' gestation or upon reaching fetal lung maturity is often recommended 4.

Complications

  • Monoamniotic twin pregnancies are associated with a high risk of perinatal death, with perinatal mortality rates ranging from 28-60% 5.
  • Cord entanglement can lead to intrauterine death of one or both twins, and is a major contributor to the high perinatal mortality rates in monoamniotic twin pregnancies 6, 5.
  • Twin-twin transfusion syndrome is another complication that can occur in monoamniotic twin pregnancies, which can further increase the risk of perinatal mortality 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Managing Monoamniotic Twin Pregnancies.

Clinical obstetrics and gynecology, 2015

Research

Monoamniotic twin pregnancy and cord entanglement: a clinical dilemma.

The Australian & New Zealand journal of obstetrics & gynaecology, 1996

Research

Early prenatal diagnosis of cord entanglement in monoamniotic multiple pregnancies.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.